>>> Europe : Brokers Upgrades & Downgrades - 20th of October 2025

>>> Up
* ADP Raised to Overweight at Morgan Stanley; PT 139 euros
* Darden Raised to Buy at Goldman; PT $225
* Ithaca Energy Raised to Buy at Jefferies; PT 220 pence
* Johnson & Johnson Raised to Outperform at Daiwa; PT $203
* PZU Raised to Outperform at Oddo BHF; PT 66 zloty
* Sempra Raised to Overweight at Barclays; PT $101
* Siltronic Raised to Buy at Jefferies; PT Raised from 45 to 75 euros
* Tomra Raised to Buy at ABG; PT 150 kroner
* Tomra Raised to Buy at Nordea; PT 145 kroner

>>> Down
* Athens Intnl Airport Cut to Underweight at Morgan Stanley
* Digital 9 Infrastructure/Fund Cut to Underweight at Barclays
* Fraport Cut to Equal-Weight at Morgan Stanley; PT 82 euros
* Humble Group Cut to Hold at Nordea
* KKR Real Estate Finance Cut to Neutral at JPMorgan; PT $9
* Marvell Technology Cut to Equal-Weight at Barclays; PT $80
* Metsa Board Cut to Hold at SEB Equities; PT 2.80 euros
* Talenom Cut to Reduce at Inderes; PT 3.80 euros

>>> Initiation
* Billerud Rated New Buy at SB1 Markets; PT 115 kronor
* Cava Group Rated New Neutral at Goldman; PT $74
* Cicor Tech Rated New Buy at Pareto Securities
* Deutsche Bank Rated New Hold at Jefferies; PT 33 euros
* Dedem Rated New Outperform at EnVent S.p.A.; PT 7.90 euros
* Xplora Technologies Rated New Buy at Pareto Securities

>>> Call

>>> What to look at today - 20th of October 2025

Asian equities traded above their record closing high as signs of easing trade frictions helped boost sentiment after recent volatility tied to concerns about US regional banks. MSCI’s regional stock gauge jumped 1.7% and futures indicated gains in the US and Europe. Japanese shares rallied almost 3% and the yen pared its declines on expectations the pro-stimulus Sanae Takaichi will be elected as Japan’s next prime minister. Chinese equities gained as investors looked past data that showed economic growth slowed to the weakest pace in a year. In other corners of the market, Treasuries edged lower across the curve with the yield on the 10-year rising one basis point to 4.01%. A gauge of the dollar was flat, while oil dipped after posting a third weekly decline. Market sentiment improved as President Donald Trump sought to ease trade tensions with China after markets were rattled on Friday by US bank-credit woes. A new round of US-China trade talks is set for this week with Treasury Secretary Scott Bessent and Vice Premier He Lifeng facing the task of negotiating down new escalatory measures.  When asked by Fox News on Sunday about his threat to raise the tariff on Chinese goods by 100%, Trump said the levy was “not sustainable,” though “it could stand.” The US will “be fine” with China, he added. Bessent also had a “frank and detailed” discussion with He and reaffirmed plans to meet in-person next week. Those comments came as Trump expressed optimism that talks with Chinese officials may yield an agreement to defuse the crisis that saw the US leader threaten to drastically hike tariffs.  Ning Zhang of UBS Investment Bank shares his views on China’s third quarter GDP data. He tells Bloomberg Television that China’s growth is slowing down “but with huge divergence.” The remarks signaled an effort by Washington to calm fears of a full-blown trade war with China that could have a seismic effect on the global economy. From the delayed US inflation report for September, to a high-level party meeting in China and a busy week of earnings — including Netflix Inc. and Tesla Inc. — it’s a packed week for investors. September’s consumer price index, originally set for Oct. 15, will now come on Friday. In China, political leaders will begin gathering in Beijing for a four-day meeting, known as its Fourth Plenum, with traders watching for fresh measures to extend China’s strongest equity rally in eight years and shore up the yuan.  While a detailed plan will only be released in March next year, investors will scrutinize the post-meeting readout for any policy signals ahead of the possible meeting between Chinese President Xi Jinping and Trump. Elsewhere, French bond futures dropped after S&P Global Ratings downgraded France to A+ from AA-, saying the country’s budget uncertainty was “elevated.” France has now lost its double-A rating at two of the three major credit assessors in little more than a month, potentially forcing some funds with ultra-strict investment criteria to sell the country’s bonds. In geopolitical news, Israel launched strikes against Hamas in Gaza and reportedly suspended all aid shipments on Sunday after blaming Hamas for a lethal Palestinian ambush that left two soldiers dead.  

Nikkei +3.02% Hang Seng +2.26% CSI +0.44% Shanghai +0.43% Shenzen +0.66%

Eur$ 1.1667 CNH 7.1250 CNY 7.1245 JPY 150.68 GBP 1.3438 CHF 0.7931 RUB 81.2299 TRY 41.9557 WTI$ 57.30-0.42% Gold 4,263 +0.28% BTC 110,069 +0.28% ETH 4,031 +0.68%

S&P +0.41% Nasdaq +0.53% EuroStoxx +0.82% FTSE +0.41% Dax +0.77% SMI +0.42%

Macro :
- China Says Growth Target in Reach Despite Rare Investment Drop
- UK Closes in on Drug Pricing Deal With White House: FT
- Oil Risks Drop To $50 on Russia-Ukraine De-escalation, Citi Says
- France Downgraded to A+ by S&P, Outlook Stable, France Gets Debt Alert as S&P Downgrades in Unscheduled Move
- Trump Extends Auto Tariff Relief, Imposes Truck and Bus Duties
- Can Gold Keep Rising? Depends if You Think This Time Is Different - WSJ
- Pakistan, Afghanistan Agree to Immediate Ceasefire in Doha Talks
- Apollo Global chief says Europe ‘at war with itself’ over finance regulation - FT
- Palmer Luckey says Anduril has an internal 'China 27' strategy to prepare for a war over Taiwan

Keep an eye on :
- AF FP : Air France to Resume Flights to Madagascar Saturday: AFP
- AIRT US : Nasdaq-listed air operator Air T to buy Rex
- AMD US : Nvidia, Broadcom and AMD Face New Risks From OpenAI Deals - The Information
- AAPL US : Apple announces F1 races are coming exclusively to Apple TV in the US - 9to5
- AAPL US : Apple’s New iPhone Outsells Previous Model by 14% in US, China
- ARYN SW : Aryzta 3Q Revenue EU554.3M
- ASML NA : Meet AMIES, China’s new hope in breaking reliance on ASML’s chipmaking machines - SCMP
- AZN LN ; Amgen, AstraZeneca Get FDA Approval for Tezspire to treat CRSwNP
- AZN LN : Daiichi, Astra’s Breast Cancer Drug Improves Survival in Trial - FT
- BYW6 GY : BayWa Says Its Negotiating With New Investor to Acquire Cefetra
- BA US : IAM 837, Boeing Agree to Resume Mediation on Monday
- BA US : Federal Aviation Administration Says Boeing Can Hike Monthly Production Of 737 Max To 42 Planes Per Month Up From 38
- CCO US : Mubadala Capital Is Said to Explore Buying Clear Channel Outdoor
- COO US : Activist Jana Takes Stake in Cooper, a Maker of Medical Devices - WSJ
- CVC NA : CVC-Backed FineToday Cancels Tokyo IPO Citing Market Conditions
- BN FP : Danone CEO Says Global Food Industry Is at ‘Tipping Point’: FT
- EDP PL : ERSE Proposes 1% Boost in 2026 Tariffs for Low Electricity Users
- EQT SS : EQT-Backed Biotech Evommune Seeks $159 Million in US IPO
- FRVIA FP : Forvia 3Q Sales Beat Estimates
- GMAB DC : Genmab’s Rina-S Shows 50% Orr in Study Follow-Up of 1 Year
- GILD US : Gilead’s Trodelvy Shows Success in Phase 3 Breast Cancer Trial
- GIVN SW : Givaudan: Q3 beat driven by Fine Fragrance
- RMS FP : How a Handyman’s Wife Helped an Hermès Heir Discover He’d Lost $15 Billion - WSJ
- RMS FP : At Hermès, a New Menswear Designer May Not Bring Much Disruption - WWD
- HOLN SW ; Holcim to buy Xella, Transaction Value of €1.85 Billion
- HOLX US ; Blackstone, TPG Are Said to Near Deal to Acquire Hologic
- KER FP : Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L’Oréal, Deal would be an early move by new Kering CEO Luca de Meo to revive luxury giant’s fortunes - WSJ
- LSEG LN : UK Chancellor Considering ISA Share Ownership Overhaul, FT Says
- LHA GY : Reportedly considering cutting 100 domestic flights per week in summer 2026 - German press
- MC FP : L’Oréal bid for Kering Beauty puts LVMH in pole position for Armani - Miss Tweed
- MANU US : Eric Cantona asked to front Manchester United takeover bid by UAE consortium
- META US : WhatsApp changes its terms to bar general purpose chatbots from its platform - TechCrunch
- MNG LN : Royal London, M&G to Enter Europe’s Active ETF Market: FT
- MOWI NO : Mowi’s Purchase of Nova Sea Approved by EU Commission
- NKTR US : Nektar Therapeutics, the US biopharmaceutical company, is at the centre of takeover rumours. - Betaville
- NVDA US : Nvidia, TSMC Unveil First Blackwell Wafer Produced in the US
- NOVOB DC : Novo’s Rybelsus Approved by FDA to Reduce Cardiovascular Risk - details
- OR FP : Kering and L’Oréal Say They Are Entering Strategic Partnership
- PFE US : Pfizer Treatment Shows Survival Benefit in Lung Cancer Trial
- P911 GY : Porsche’s New CEO Is a Luxury Leader With a Knack for Hybrids
- Revolut IPO : Revolut, Backers Near End of $3 Billion Fundraising Spree
- ROG SW : Roche’s Gazyva/Gazyvaro Gets FDA Approval for Lupus Nephritis
- SZG GY : Salzgitter Profit May Rebound as One-Time Costs Fade: 3Q Preview
- SAN FP : Sanofi Influenza Vaccine Shows High Protection for Older Adults
- SOBI SS : Sobi Prelim 3Q Revenue Matches Estimates; Raises Outlook
- TKMS GY : Thyssenkrupp floats submarine business as defence stocks surge - FT
- VWS DC : Vestas Shelves Plan To Open Its Biggest Polish Plant In 2026: FT
- xAI IPO : CEO Musk: My estimate of the probability of Grok 5 achieving AGI is now at 10% and rising

>>> Quick Reminder of Kering Beauty Strat & Events

Kering & Perfume: Key Milestones
  • 2008 — Exit YSL Beauté manufacturing; move to licensing.
    PPR (now Kering) sold Yves Saint Laurent Beauté to L’Oréal for ~€1.15bn; L’Oréal got long-term rights to YSL fragrances/cosmetics. This set the template: Kering houses leaned on external beauty partners.
  • 2010s — Licenses concentrated with Coty.
    Coty held (or later confirmed) licenses tied to Gucci (a Coty pillar) and, across the period, Alexander McQueen, Balenciaga, Bottega Veneta, etc. (various waves over the decade).
  • Feb 2023 — Kering creates “Kering Beauté.”
    The group brings beauty back in-house as a growth pillar; Raffaella Cornaggia (ex-Estée Lauder) appointed CEO to build beauty for Bottega Veneta, Balenciaga, Alexander McQueen, Pomellato, Qeelin.
  • Jun 2023 — First big bet: Creed.
    Kering Beauté acquires The House of Creed (niche luxury fragrance) for ~€3.5bn (reported), aiming to anchor the division with a profitable, fast-growing label.
  • 2024 — In-house launches/relaunches.
    Kering signals new perfumes for Bottega Veneta by year-end, followed by Balenciaga and Alexander McQueen; Bottega’s line is relaunched.
  • Oct 2025 — Strategic U-turn: Sale to L’Oréal.
    Under new CEO Luca de Meo, Kering agrees to sell Kering Beauté (incl. Creed) to L’Oréal for ~€4bn and to grant 50-year exclusive licenses for Gucci (effective after current Coty license expires, widely reported as 2028), Bottega Veneta, and Balenciaga. The deal also sets up a strategic committee and a wellness/longevity partnership between the groups. Closing targeted H1 2026.

What it means
  • 2008–2022: “Asset-light via licenses.”
  • 2023–2024: “Build an in-house beauty arm (Creed as cornerstone).”
  • 2025–>2026: “Refocus on fashion; monetize beauty** (cash in Creed + lock long-term royalties via 50-year licenses to L’Oréal; Gucci transitions after Coty’s term).”

>>> TradeGate Pre-Market Indications

DAX:
  • Rheinmetall (RHM TH) +2.1%
  • Infineon (IFX TH) +1.5%
  • Siemens Healthineers (SHL TH) +1.5%
  • Deutsche Bank (DBK TH) +1.1%
    • Deutsche Bank Rated New Hold at Jefferies; PT 33 euros
  • Continental (CON TH) +1.1%
MDAX:
  • United Internet (UTDI TH) +4.7%
  • RENK Group (R3NK TH) +4.3%
  • Hensoldt (HAG TH) +3.2%
  • Redcare Pharmacy NV (RDC TH) +2%
  • DWS (DWS TH) +1.7%
  • Fraport (FRA TH) -2%
    • Fraport Cut to Equal-Weight at Morgan Stanley; PT 82 euros
  • Thyssenkrupp (TKA TH) -20%
    • TKMS Expects First Day of Trading in Frankfurt Oct. 20 (Oct. 13)
SDAX:
  • Siltronic (WAF TH) +5.8%
    • Siltronic Raised to Buy at Jefferies; PT 75 euros
  • PNE AG (PNE3 TH) +2.6%
  • Grand City Properties (GYC TH) +2.3%
  • Duerr (DUE TH) +1.8%
  • Hamborner REIT (HABA TH) +1.7%

>>> Kering / L'Oreal Deal - First Thoughts (me)

Summary :
L’Oréal will pay €4B for a 50-year beauty and fragrance licensing deal with Kering brands (Gucci, Bottega Veneta, Balenciaga) and acquire Creed. The transaction injects liquidity into debt-heavy Kering (net debt €9.5B), enabling restructuring while offloading its underperforming beauty ambitions. For L’Oréal, it massively strengthens dominance in luxury fragrances (fastest-growing beauty segment) and adds exposure to high-margin niche perfume and wellness markets.

Implications :
* Bullish L’Oréal: Strengthened luxury portfolio, long-term recurring revenues, synergies with existing brands (YSL, Prada, Armani). Potential EPS accretion post-2028 when Gucci license activates.
* Short/Mildly Bearish Kering: Near-term liquidity relief but signals strategic retreat and value destruction (paid €3B for Creed, selling beauty arm for €4B). Focus now on deleveraging, cost cuts, and Gucci turnaround.
* Sector Impact: Puts pressure on Coty (Gucci license loss by 2028), Puig, and Estée Lauder; could trigger further M&A activity in prestige and niche fragrance. Expect multiple re-ratings and rotation toward dominant players (L’Oréal, Estée) over fragmented independents

WWD : Why L’Oréal’s Deal With Kering Beauty Is a Category Game-changer

Why L’Oréal’s Deal With Kering Beauty Is a Category Game-changer
“It has implications for everyone,” one industry expert said.

Kering and L’Oréal have made it official: The two French giants announced that they are forming a long-term strategic partnership in beauty and wellness.

In a joint announcement, the companies said the binding agreement encompasses the acquisition of the House of Creed by L’Oréal, and gives L’Oréal the rights to enter into a 50-year exclusive license for the creation, development and distribution of fragrance and beauty products for Gucci, commencing after the expiration of Kering’s current license with Coty for that business.

Kering acquired Creed, the oldest existing high-end niche fragrance house, in June 2023 in a blockbuster deal thought to be in the high 2 billion euro range.

The partnership will also include 50-year exclusive licenses for Bottega Veneta and Balenciaga, which will start at the close of the transaction. These will join other designer fragrance brands already in the L’Oréal Luxe division, which includes Yves Saint Laurent (a Kering brand), Armani, Valentino, Prada, Miu Miu, Jacquemus, Mugler, Azzaro, Maison Margiela, Viktor & Rolf, Ralph Lauren, Diesel and Cacharel.

The 50/50 joint venture agreement is valued at 4 billion euros, payable in cash at the closing, which is expected to take place in the first half of 2026. L’Oréal will also pay royalties to Kering for the use of its licensed brands.

Beyond beauty, the companies said they are joining forces to explore business opportunities at the intersection of luxury, wellness and longevity.

“This strategic alliance marks a decisive step for Kering,” said chief executive officer Luca de Meo in a statement. “Joining forces with the global leader in beauty, we will accelerate the development of fragrance and cosmetics for our major houses, allowing them to achieve scale in this category and unlock their immense long-term potential.”

For his part L’Oréal CEO Nicolas Hieronimus said, “I am delighted to forge this long-term alliance with one of the world’s most prestigious, creative and visionary luxury groups. The addition of these brands significantly expands our reach into new, dynamic segments of luxury beauty. Through Creed, we will establish ourselves as one of the leading players in the fast-growing niche market.”

“This is a real game-changer. It is earth-shattering,” said an industry expert of the L’Oréal-Kering Beauty deal. “It has implications for everyone.”

For Kering, it will provide a much-needed injection of cash to reinvest in its struggling brands, and is a bold move by de Meo, who took the reins in September and has wasted no time in making changes. In addition to a deal for the beauty, industry sources indicate he is also looking to shed the company’s eyewear business. Both were key pillars of the strategy implemented by former CEO François-Henri Pinault, who seems to be abiding by his pledge to give de Meo free rein in executing his own vision even as Pinault remains company chairman.

“To build a beauty company takes a lot of time, and it’s very different from fashion, even though there are synergies on the brand side,” said Laurent Droin, a partner and investor in Felix Capital.

“For L’Oréal, it makes a lot of sense, because it’s a unique opportunity to acquire a real luxury beauty portfolio,” he added. “This makes sense for both parties.”

Many insiders predict the deal could reshape not only the market’s landscape, but also force some company and brand marriages that were not on the horizon otherwise.

A deal could be pivotal for midsize beauty brands held by private equity concerns, which had been banking on L’Oréal to acquire them as other major beauty groups struggle to find their footing.

With this deal, L’Oréal is significantly bolstering its position in perfumes — the beauty market’s largest category driver over the past six years, since the coronavirus pandemic began. Within that, niche fragrances are the strongest segment.

Overall, the worldwide fragrance market is highly fragmented and large — expected to generate sales of $62.11 billion this year, according to Statista. The category’s growth might be mitigating currently, but its outlook remains strong. This in part is due to fragrances’ expanding scope that is morphing, moving into new geographies such as Asia and the well-being sector with functional attributes.

Fashion fragrances, which sell particularly well in the West, are increasingly serving as launchpads for fashion-branded makeup, an increasingly hot category in the East.

Many industry analysts weren’t surprised that Kering is abandoning its efforts to build a beauty business on its own. “Kering spent 3 billion euros on Creed and they are selling everything for 4 billion — the value destruction is incredible,” said one insider. “It’s very tough for these firms to take beauty in-house. Burberry tried it a few years ago and Coty picked up the beauty business because they realized they couldn’t do it. Kering is the same.”

As it is, the deal will almost certainly have implications for the major players in the category, including Coty Inc., the Estée Lauder Cos., Puig and Interparfums.

“It puts more pressure on everyone,” Droin said.

The move comes at a time of great change in beauty. As first reported by WWD in June, Coty’s future remains uncertain as the company explores potential sell-offs of its luxury and consumer divisions, according to industry sources.

Coty’s Luxury division includes fragrance brands such as Gucci, Burberry, Jil Sander and Hugo Boss. If L’Oréal acquires Kering Beauty and Coty does look to divest its prestige fragrance holdings ultimately, it could intensify the scramble to take over those brands.

Meanwhile, the Estée Lauder Cos. is increasingly leaning into its perfume activity. Last week, its CEO Stéphane de La Faverie said fragrance is the future of the group, as it inaugurated La Maison des Parfums, a prospective innovation arm for perfume, in central Paris. That is meant to accelerate its fragrance business around the world.

Puig was in the running to acquire Kering Beauty. A Puig spokeswoman could not be reached for comment Sunday.

Already a number of fragrance licenses held by Puig — such as Valentino, Prada and Miu Miu — have migrated to L’Oréal.

Questions remain about another possible big L’Oréal acquisition. The company is among the three preferred bidders listed in the will of Giorgio Armani, who died on Sept. 4. After 12 months from the opening of the will and within 18 months at most, an initial 15 percent of his namesake company could be sold either to LVMH Moët Hennessy Louis Vuitton, EssilorLuxottica or L’Oréal.

On Sept. 12, L’Oréal said in a statement: “We will study, with great consideration, this opportunity building on our long-shared history.”

Giorgio Armani and L’Oréal have had a long-standing fragrance and beauty license, which was renewed in March 2018 to run through 2050. Fragrance and eyewear represent a significant portion of Armani’s global revenues.

On the M&A front, L’Oréal had been cherry-picking brands to acquire on an individual basis, most recently including Color Wow and Medik8. It also won the fragrance license of and acquired a minority stake in Jacquemus. In 2023, L’Oréal took over Aesop in a major deal.

Industry sources believe the partnership could trigger concern among private equity executives.

“L’Oréal made a clear choice between acquiring a pre-backed indie brand and a big acquisition like this,” said one industry expert. “They are on a tear at a time when everyone else is asking: ‘Should we buy Makeup by Mario or what’s happening with Glow Recipe?’” this person continued, referring to two buzzy indie brands that are said to be pursuing sales. “L’Oréal sees the entire market, from mass to high-end.”

Some niche perfume brands owned by PE players are reaching or have recently reached critical mass, whereby they could be ripe for a sale soon. Industry sources named as examples Parfums de Marly and Initio Parfums Privés, held by Advent International, and Kayali, the perfume brand earlier this year that was bought from parent company Huda Beauty by Mona Kattan and General Atlantic.

Kering began taking its fashion and jewelry-related beauty activities back in-house in early February 2023, when it announced the appointment of Raffaella Cornaggia as CEO of Kering Beauty.

There were great expectations. Luxury goods companies have been taking back full control of the brands they own in a bid to obtain greater consistency, synergies and power.

Since the birth of Kering Beauty, beside acquiring Creed, the division has focused on relaunching Bottega Veneta and Balenciaga fragrances with perfume collections. Balenciaga fragrances also have an individual store. Those businesses remain small.

In June 2024, Kering took a minority stake in niche perfume brand Matière Première.

Two jewels in Kering’s crown are Gucci and Yves Saint Laurent. The Gucci fragrance license, expected to expire in 2028, brings in a sizeable income. One industry source estimated it generates $1.1 billion in net sales annually.

It is understood that under terms of Coty’s contract, should Kering wish to break it prior to 2028, Kering would have to pay Coty the expected annual revenues each of the remaining years.

“For L’Oréal, the timing will be perfect — by 2028, they will have integrated the Kering brands and blown out Creed and it will be easy for them to absorb Gucci,” said one source, “and this way Kering doesn’t have to write Coty a big check to buy out the contract.”

Kering has been dragged down by steep declines at its once star brand Gucci and a bulging debt load. At June 30, net debt amounted to 9.5 billion euros.

The group recently named a new designer at Gucci, Demna, who moved over from Balenciaga, where Pierpaolo Piccioli stepped in, and has been closing stores, selling real estate and reducing headcount after a dismal start to this year that saw group net profit plummet 46 percent in the first half.

To help reduce the debt ratio, Artémis, the Pinault family’s holding company that owns 42.3 percent of Kering, would keep its options open about selling its 29 percent stake in German sporting goods firm Puma. Industry sources say that Kering is also considering spinning off its eyewear division, among other divestitures.

A Kering spokeswoman could not be reached for comment on Sunday.

In 2016, Kering took back its eyewear business from Safilo Group SpA and grew the entry-level category in-house. Industry experts said that gave Kering the confidence to make a similar move in beauty.

During recent analyst meetings, Kering had been touting eyewear and beauty as solid revenue earners at a time when fashion has been highly cyclical. But big change is afoot under de Meo.

“We will initially focus our efforts on the most effective levers to improve the quality of our capital allocation and generate a tangible operational rebound,” he said on Sept. 9. “We will have to continue to reduce our debt, cut our costs and, where necessary, rationalize, reorganize and reposition some of our brands.”

A day later, Kering and Mayhoola jointly announced that the current ownership structure of the Valentino house will not change before 2028 at the earliest, marking an amendment to their shareholders’ agreement inked at the time of Kering’s acquisition of a stake in Valentino in 2023.

As per the original deal, when Kering bought a 30 percent stake in Valentino for 1.7 billion euros in cash, the French group had an option to buy 100 percent of Valentino’s capital by 2028. Mayhoola could become a shareholder in Kering, with the purchase price linked to the Italian fashion brand’s performance.

“This was already a signal, when Kering said they would not exert their right-to-buy option,” said Karine Ohana, managing partner of independent investment bank Ohana & Co.

In the first half of this year, Kering Beauty’s sales were 150 million euros, up 9 percent on a reported and comparable basis. In the second quarter of 2025, the division’s sales rose 12 percent in like-for-like terms, driven especially by Creed women’s fragrances’ strong performance, Kering said.

In 2022, the year before Creed’s acquisition, the brand generated revenues of around 250 million euros with a high EBITDA margin. Opportunities for brand development included the Asia-Pacific region, where it had limited exposure; travel retail, where it had little to no presence, and women’s scents, which could be expanded.

The Creed deal came after Kering was in the chase to acquire Tom Ford International, which eventually was bought by that company’s existing beauty licensee, the Estée Lauder Cos., for $2.3 billion. Kering was also reportedly interested in acquiring luxury brand Byredo, which was snapped up by Puig, for an estimated 1 billion euros.

“Maybe Creed was too big an acquisition for Kering,” another industry source said. “If they had started smaller it might have been better, but clearly putting 3.5 billion euros in one asset puts so much pressure on people and the beauty division.”

The multiple paid for the brand was extremely high, especially for a non-native beauty-player to pay.

“Once you have that kind of money invested in your business, you need to deliver,” the source continued. “It was a big bet to start with Creed. They should have built it more steadily on the long run without too much investment.”

SCMP : Live long and prosper: Chinese scientists find age-well protein in naked

Live long and prosper: Chinese scientists find age-well protein in naked mole-rats
Longevity of the rodent family could inspire new therapeutic anti-ageing strategy to improve the health and lifespan of humans, study suggests

The remarkable longevity and disease resistance of naked mole rats are linked to a version of a protein involved in DNA repair that is also found in humans, Chinese scientists have discovered.

The team led by researchers from Shanghai’s Tongji University found that introducing this modified protein in flies and mice reduced the genetic damage associated with ageing and helped to extend lifespan, according to results of their study published earlier this month.
Their findings suggest that the longevity of naked mole rats could inspire a new therapeutic anti-ageing strategy to improve the health and lifespan of humans.

“Our work provides a molecular basis for how DNA repair is activated to contribute to the exceptional longevity during evolution in naked mole-rats,” the team said in a paper published in the peer-reviewed journal Science on October 9

Naked mole-rats are burrowing rodents with a maximum lifespan of around 37 years, which is extraordinary for a mammal of their size.

These hairless rodents not only have a long lifespan, but are also extremely resistant to cancer and age-related symptoms and conditions.

Naked mole-rats also have protein coding sequences and messenger molecules that are more similar to humans than mice, making them a good model to study the molecular mechanisms behind successful ageing, according to the team.

These unique traits have spurred research into the genetic adaptations that protect them from genomic instability – a primary cause of ageing – such as an increase in DNA damage and a decline in DNA repair capacity.

Earlier studies have found that an enzyme called cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) is involved in initiating immune defence responses and plays a role in DNA repair.

In humans and mice, cGAS suppresses a type of DNA repair known as homologous recombination within the cell’s nucleus. Defects in this repair pathway have been associated with premature ageing.

The team, which also included researchers from Fudan University, Central South University and the Chinese Academy of Sciences, found that the opposite was true in naked mole-rats.

After studying the naked mole-rat cGAS, the researchers found that it had changes in four specific amino acids, or protein building blocks. These changes allowed their cGAS to enhance rather than inhibit this kind of DNA repair.

“This alteration confers naked mole-rat cGAS with a greater capacity to stabilise the genome, counteract cellular senescence and organ ageing, and promote extended lifespan and health span,” the team said.

Cellular senescence is a state in which cells stop dividing but do not die, and the accumulation of such cells is linked to age-related diseases.

“Manipulating cGAS might therefore constitute a mechanism for lifespan extension,” the researchers said.

The team found that fruit flies expressing the naked mole-rat cGAS had reduced cellular senescence, less organ degeneration, and an extended lifespan.

In mice, expressing naked mole-rat cGAS reduced frailty and hair greying, and decreased cellular senescence markers in multiple tissues.

The team also examined the role of human versus naked mole-rat cGAS in tumour formation, and found that the human cGAS promoted cell transformation to a cancerous state, which could be prevented by making those four amino acid substitutions.

“These findings support the notion that efficient DNA repair decelerates the ageing process and raise the possibility that targeting cGAS to enhance DNA repair could provide an intervention strategy for promoting longevity,” the researchers wrote.

WSJ : Wealthy Families Are Writing Mission Statements to Avoid Fights, Lost Fort

Wealthy Families Are Writing Mission Statements to Avoid Fights, Lost Fortunes
Advisers help families spell out their values for generations to come

  • Wealthy families are increasingly using mission statements to preserve wealth and family cohesion across generations.
  • These statements, while not legally binding, aim to prevent disputes and ensure younger generations manage fortunes responsibly.
  • Advisers like UBS and J.P. Morgan Private Bank assist families with assets typically exceeding $50 million in crafting these declarations.

Serial entrepreneur and investor James Harold Webb has done careful investment and estate planning to pass down his wealth to his five children, their three spouses, and six grandchildren. He also got everyone together to write a family mission statement.

“The entire goal is to preserve the family and to preserve the wealth,” said Webb, 65 years old, whose ventures include buying and building 33 Orangetheory Fitness franchises in Texas that he sold to private equity.

The mission statement for his 16-person blended family: “Life is a gift that cannot be wasted. Family is the essence of that life and, as a family, we will work hard. We will play hard. We will live in the pursuit of knowledge. We will love our family unconditionally. We will give more than we take to ensure a better world.”

A family mission statement lays out principles and goals in a few sentences. The aim is to avoid the fighting that has destroyed fortunes and left relatives battling in court, or just make sure younger generations don’t squander the fortune.

Behind the trend is the extraordinary wealth creation in recent years and a boom in ​​family wealth and concierge services catering to it.

Sometimes known as a declaration of purpose or vision, mission statements aren’t legally binding. Some advisers embrace the statements as a way to increase a family’s chances of what they consider success, preserving their wealth for a century or more.

Advisers point to Gilded Age dynasties that have disappeared to warn about depleted fortunes and families that no longer are connected. Wealth advisers like to reference a 2023 book written by Victor Haghani and James White, “The Missing Billionaires,” which notes how rare it is for great family fortunes to last beyond a few generations.

Some families opt for a more robust, legalistic document, called a constitution. For families that own businesses, constitutions can lay out what minimum requirements family members and their spouses must meet to be able to work at the business. To try to avoid drama later, they also can define who even counts as family, such as stepchildren.

Some family members put the mission statement on the back of their business cards or hang them, framed, on a wall at home.

“It’s going to be the family’s why. Why are we doing what we’re doing? Why are we making all this money?” said Shawn Barberis, whose firm, More Than Money 360, works with families including Webb’s to create mission statements and prepare the next generation for leadership. “Every family gets off the tracks a little bit and it can get them refocused.”

Webb was born to teenage parents in rural Mississippi. He says he is astonished that he has been able to create what he calls “generational wealth” for his family, including from a medical-imaging business he sold in 2017 for $94 million. He and his wife, Cathy, split their time between Frisco, Texas, and San José del Cabo, Mexico.

Webb and his wife, plus the children and their spouses, sat around a conference room at a Frisco hotel several years ago to come up with their mission statement at the encouragement of Barberis, with whom they’d started working several years after they got married. With Barberis guiding the discussion, Webb and his family spent a few hours talking about what was important to them to brainstorm their mission statement.

Webb now kicks off his family’s annual meeting by reading the mission statement aloud and leading a discussion of whether it needs revision. Then, he updates the family on his finances and estate plans before they break for games and a meal.

The mission statement by itself isn’t enough to hold the family together long-term, Webb said. But, coupled with transparency and financial education, he figures his family has a shot at maintaining its wealth for generations.

At UBS, which has a big business advising wealthy families, Sarah Salomon, head of family advisory and philanthropy, and her team help families that typically are worth at least $50 million write mission statements. They’ll often kick off discussions by handing each family member a pack of cards inscribed with words such as “curiosity,” “reliability” and “spirituality”—and asking them to choose the cards that resonate with them the most.

Advisers sometimes have family members look at a series of images and riff on what they see. A photo of redwood forests, said Elisa Shevlin Rizzo, head of family office advisory at J.P. Morgan Private Bank, has prompted themes of permanence and environmental stewardship.

“If we know one of our core values is stewardship and legacy, maybe we don’t use the trusts for current consumption to fund extravagant lifestyles,” Rizzo said.

Colorado vacation homes and luxurious Airbnbs in Utah are popular sites for brainstorming mission statements, Salomon said. She typically steers clients away from offices, preferring settings where family members can relax and reflect.

WSJ : Activist Jana Takes Stake in Cooper, a Maker of Medical Devices

Activist Jana Takes Stake in Cooper, a Maker of Medical Devices
Bausch + Lomb is considered a potential partner for contact-lens unit, and CEO says he would be interested

Activist investor Jana Partners has built a stake in Cooper COO 0.57%increase; green up pointing triangle Cos. and plans to push for strategic alternatives, including a potential deal to combine its contact-lens unit with rival Bausch + Lomb BLCO 0.53%increase; green up pointing triangle, according to people familiar with the matter.

That idea already has the rival’s support, with Bausch + Lomb Chief Executive Brent Saunders, a regular dealmaker, saying in an interview that he would be interested in such a combination.

The details
Jana also plans to push Cooper to make other changes that could help lift shares, including through improving capital allocation and returns, the people said. The exact size of its stake couldn’t be learned.

The global medical-device manufacturer makes contact lenses and vision-care products through its CooperVision segment and provides products and services for women’s health and fertility through CooperSurgical. CooperVision is one of the largest producers of soft contact lenses.

The activist believes the company’s two business units are unrelated and lack synergies, the people said. It also believes the company’s strategy has generated little value for shareholders, leaving a more complicated business with poor capital allocation, the people added.

California-based Cooper has a market value of $14 billion, after its share price has dropped more than 20% so far this year.

The company has maintained it remains confident in its strategy and being in two different, growing markets.

Jana sees potential buyers for both the contact-lens and women’s health businesses.

Among potential combinations, Jana thinks that a tie-up between Cooper’s and Bausch + Lomb’s contact-lens businesses would be attractive to investors, the people said.

Bausch + Lomb, which has a roughly $5.3 billion market capitalization, had itself been spun out of a bigger health company under Saunders.

“A potential combination with Cooper would strengthen competition and create a more scaled company in the contact-lens segment,” Saunders told The Wall Street Journal on Sunday.

Bausch + Lomb and Cooper both compete with Johnson & Johnson and Switzerland-based Alcon in the space.

The context
Cooper has recently underperformed its peers in its core contact-lens segment and reported declining margins in women’s health. In its women’s health segment, a decision to pursue billions of dollars of acquisitions in recent years has yet to bear fruit and instead weighed on the segment’s operating margins.

Cooper reported total sales of $3.9 billion in 2024, with its CooperVision business accounting for over two-thirds of that.

Jana previously pushed for a strategic review at the telecom company Frontier Communications, which ended up getting bought by Verizon Communications, as well as the specialty insurance company Markel, which is undergoing a review.

Earlier this year Jana struck an agreement with french-fry maker Lamb Weston, which added six board members after the activist pushed for changes.

FT : Kering agrees €4bn sale of beauty division to L’Oréal

Kering agrees €4bn sale of beauty division to L’Oréal
Deal includes rights to develop products under Gucci, Bottega Veneta and Balenciaga labels

Kering has agreed a €4bn deal to sell its beauty business to L’Oréal as its new chief executive looks to revitalise the struggling luxury group.

The agreement included the sale of its perfumer House of Creed as well as 50-year licences to develop and sell products under the Gucci, Bottega Veneta and Balenciaga labels, Kering said on Sunday.

L’Oréal will pay royalties to Kering for use of the licensed brands.

The sale, expected to close in the first half of 2026, represents a U-turn by the Paris-listed company, which had previously sought to grow its beauty business in-house.

It is also one of the first big restructuring moves by new Kering chief executive Luca de Meo, who arrived in September from carmaker Renault with a mandate to turn around the flagging business.

Kering’s shares have risen more than 60 per cent since de Meo’s appointment was announced in June.

L’Oréal owns dozens of brands ranging from Maybelline to Prada and Saint Laurent’s beauty licences.

Kering is one of the world’s biggest luxury groups but has lagged behind peers as Gucci’s performance has plummeted in recent years.

The beauty licence for Gucci, Kering’s biggest brand by sales and profits, will go to L’Oréal after its current contract with Coty expires in 2028.

“This strategic alliance marks a decisive step for Kering,” de Meo said in a statement.

“Joining forces with the global leader in beauty, we will accelerate the development of [these] fragrance[s] and cosmetics . . . allowing them to achieve scale,” the statement added.